OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

The Big Questions in Cancer Immunotherapy: Why Do “Cold” Tumors Stay Invisible to the Immune System?

FDA Grants Breakthrough Therapy Designation to Daraxonrasib Plus Chemotherapy in First-Line Metastatic Pancreatic Cancer

Muna Al-Khaifi: Understanding Cognitive Changes After Cancer

HRH Princess Dina Mired: In Memoriam of My Dear Friend Navid Madani

ADAURA at WCLC 2026: 8-Year Survival Confirms Durable Benefit of Adjuvant Osimertinib in Resected EGFR-Mutated NSCLC

Oncology News, Insights, Stories by OncoDaily

Shushan Hovsepyan
Career Updates

OncoDaily Senior Vice President Shushan Hovsepyan Named Candidate for UICC Board of Directors 2026–2028

Childhood Cancer
Not To Miss

WHO Unveils 2026–2030 Strategy to Close the Childhood Cancer Medicines Gap

Japan
Breast Oncology

Japan Approves Enhertu Plus Pertuzumab and Datroway in Two New First-Line Metastatic Breast Cancer Settings

Penn Medicine Cancer Launches the First-Ever Clinical Trial of FLASH Radiation - The Mark Foundation

David J. Skorton Announces Retirement as AAMC President and CEO

ADAURA at WCLC 2026: 8-Year Survival Confirms Durable Benefit of Adjuvant Osimertinib in Resected EGFR-Mutated NSCLC

STAMINA Trial: Lifestyle Intervention Mitigates ADT-Associated Adverse Effects in Prostate Cancer

Trump Administration Launches FDA Expedited IND Pilot to Speed First-in-Human Trials

Amol Akhade: Last day at WCLC 2026, King Keytruda survived?

FDA Grants Breakthrough Therapy Designation to Daraxonrasib Plus Chemotherapy in First-Line Metastatic Pancreatic Cancer

Voices
Fight Colorectal Cancer

CRE ARTEMIS Advances Research Into Early-Onset Colorectal Cancer - Fight Colorectal Cancer

Yüksel Ürün: ASCO Leadership Development Program Builds Stronger Leaders Together

Wafik S. El-Deiry: WIN Symposium Advances the Future of Precision Oncology

Richard Sullivan: Growing Dys-Infodemic and Misinformation in Cancer Research

Lei Peng: Proud to Receive the NIH/NCI K99/R00 Award

Ayire Adongo: Great to Meet Morgan Livingston and Her Team at SIOP 2026

Rasika Bombatkar: IASLC World Conference on Lung Cancer 2026 – Advocate Events Insights

FDA Approvals
Bexlutry

FDA Approves Curium’s Bexlutry (Lutetium Lu 177) for SSTR-Positive Gastroenteropancreatic Neuroendocrine Tumors

FDA Approves Floretyrosine F 18 for PET Imaging in Glioma

FDA Expands Accelerated Approval of Sevabertinib for HER2-Mutant Non-small Cell Lung Cancer

FDA Grants Accelerated Approval to Camizestrant for ESR1-Mutated Advanced Breast Cancer

FDA Approves Ziihera With and Without Tislelizumab Plus Chemotherapy for First-Line HER2-Positive Gastroesophageal Adenocarcinoma

FDA Approves OncoSil Device for Distal Cholangiocarcinoma

FDA Grants Accelerated Approval to Bristol Myers Squibb’s Zenbexus Plus Daratumumab and Hyaluronidase-fihj and Dexamethasone for Multiple Myeloma

OncoDaily 100
100 Influential Women

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Cancer Survivors on Social Media: 2026 Edition

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

Celebrities and Cancer

OncoCalendar

EORTC Soft Tissue and Bone Sarcoma Group Autumn Meeting 2026

European Organisation for Research and Treatment of Cancer

08 Oct
Bone Sarcoma

EORTC Head and Neck Cancer Group Autumn Meeting 2026

European Organisation for Research and Treatment of Cancer

02 Oct
Head and Neck Cancer

EORTC Lymphoma Group Autumn Meeting 2026

European Organisation for Research and Treatment of Cancer

02 Oct
Lymphoma

EORTC Breast Cancer Group Autumn Meeting 2026

European Organisation for Research and Treatment of Cancer

24 Sep
Breast Cancer

EORTC Melanoma Group Autumn Meeting 2026

European Organisation for Research and Treatment of Cancer

24 Sep
Melanoma Group

Immune-oncology
The Big Questions in Cancer Immunotherapy: Why Do “Cold” Tumors Stay Invisible to the Immune System?

The Big Questions in Cancer Immunotherapy: Why Do “Cold” Tumors Stay Invisible to the Immune System?

Trogocytosis in Cancer: How Cells Steal Each Other’s Proteins and Escape Immunotherapy

The Big Questions in Cancer Immunotherapy: Can We Predict Who Will Respond Before Treatment Starts?

Cancer Immunotherapy: 2016 vs 2026

Can Oncolytic Viruses Make CAR-T-Cell Therapy More Adaptable in B-Cell Malignancies?

A New Model of PD-1 Inhibition: Unphosphorylated Tyrosines Block T-Cell Signaling Condensate Formation

Myeloid-Derived Suppressor Cells in Cancer: How MDSCs Block Immunotherapy

Gastrointestinal-Oncology
IMHOTEP

IMHOTEP: Perioperative Pembrolizumab in Localized dMMR/MSI Esophagogastric Cancer

MATTERHORN: Durvalumab Plus FLOT Improves OS in Resectable Gastric and GEJ Adenocarcinoma

10 Must-Read Posts In GI Oncology This Week

Phase 3 EMERALD-3 Trial: STRIDE ± Lenvatinib Plus TACE in Embolization-Eligible HCC

Why Gastric Cancer Spreads Across the Abdomen: The Biology of Peritoneal Metastasis

Can Pancreatic Cancer Be Detected Early? Symptoms, Biomarkers, and New Tests

Hepatocellular Carcinoma and Viral Hepatitis: How HBV and HCV Drive Liver Cancer

Breast-Oncology
Japan

Japan Approves Enhertu Plus Pertuzumab and Datroway in Two New First-Line Metastatic Breast Cancer Settings

Japan Approves Trastuzumab Deruxtecan and Datopotamab Deruxtecan for New First-Line Metastatic Breast Cancer Indications

BRCA-Mutated Early TNBC Shows Worse Outcomes Despite Adjuvant Capecitabine in Real-World Study

Breast Cancer Brain Metastases Harbor Actionable Genomic Alterations: Could the Brain Lesion Become a Precision-Oncology Target?

SERENA-4 Misses Its Primary Endpoint: What the First-Line Camizestrant Result Means for HR-Positive Breast Cancer

SERENA-4 Phase III Trial Misses Primary PFS Endpoint for Camizestrant Plus Palbociclib in First-Line Advanced Breast Cancer

Breast Cancer ADC Trials 2026: Critical PFS–OS Gap Revealed

Lung-Oncology
DESTINY-Lung04

DESTINY-Lung04 Redefines First-Line Treatment in HER2-Mutant NSCLC, With PFS Benefit but No Current OS Advantage

ADAURA at WCLC 2026: 8-Year Survival Confirms Durable Benefit of Adjuvant Osimertinib in Resected EGFR-Mutated NSCLC

Tambotatug Pelitecan Delivers a Major Survival Gain in Relapsed SCLC: TAISHAN-302 Establishes B7-H3 as a Therapeutic Target

Osimertinib Shows Sustained 8-Year Survival Benefit in Early-Stage EGFR-Mutated NSCLC in ADAURA

Trastuzumab Deruxtecan Improves PFS in First-Line HER2-Mutant NSCLC in DESTINY-Lung04

Tambotatug Pelitecan Improves Overall Survival in Relapsed Small-Cell Lung Cancer in Phase III TAISHAN-302 Trial

WCLC 2026 Opens in Seoul: Targeted Therapy Moves Earlier as SCLC Enters a New Therapeutic Era

OncoDaily TV
Lynda Chin

The Future is Near. Can We Finally Stop Cancer Resistance? Dr. Lynda Chin

AI

Can you trust AI with your CANCER? Shaalan Beg

Christian Ntizimira

Continue to be human: Christian Ntizimira

Stephanie Kauffman

She Left Hollywood To Fight Cancer: Stephanie Kauffman

pablo allard

Childhood Cancer Survivor Who Changed the Law: Pablo Allard’s Advocacy Journey

Cancer Care

Personalizing Colorectal Cancer Care with ctDNA? Dr. Robert Lentz

Priti Patnaik, Independent journalism

Independent journalism in global health: Priti Patnaik

Treatment Paradigms, Karine Tawagi

Evolving Treatment Paradigms in Muscle-Invasive Bladder Cancer

Cancer in Women

Cancer in Women As a Global Health and Economic Issue: Dr. Maira Caleffi

oncoffee, palliative

ONCOFFEE: Colorectal Cancer, Palliative Care, and the Human Side of Oncology: Santiago Fontes

Empowering Oncologists

Empowering Oncologists: How Policy impacts Medicine?

WHO

Mission is possible: WHO said 2030 – Rwanda said 2027: Dr. Sabin Nsanzimana

Not To Miss
FoundationOne CDx

FoundationOne CDx Approved in Japan as Companion Diagnostic for Tovorafenib in BRAF-Altered Glioma

Japan Approves Trastuzumab Deruxtecan and Datopotamab Deruxtecan for New First-Line Metastatic Breast Cancer Indications

Trump Administration Launches FDA Expedited IND Pilot to Speed First-in-Human Trials

WHO Unveils 2026–2030 Strategy to Close the Childhood Cancer Medicines Gap

FDA Approves Curium’s Bexlutry (Lutetium Lu 177) for SSTR-Positive Gastroenteropancreatic Neuroendocrine Tumors

FDA Grants Breakthrough Therapy Designation to Daraxonrasib Plus Chemotherapy in First-Line Metastatic Pancreatic Cancer

FDA Approves Floretyrosine F 18 for PET Imaging in Glioma

OncoGrants
Laboratory Integration Program

CRI Clinic and Laboratory Integration Program 2027

Technology Impact

CRI Technology Impact Award 2026–2027

Prostate Cancer Research

Prostate Cancer Research Early Career Fellowship 2026

PCFA

PCFA EMCR International Visiting Research Fellow 2026

Young Investigator Grant

KWF Young Investigator Grant 2027

Cancer Research Grant

Elsa U. Pardee Foundation Cancer Research Grant

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Non-Hodgkin Lymphoma NHL, DLBCL

Non-Hodgkin Lymphoma (NHL): A Practical Biological Map and Integrative Overview

Mantle Cell Lymphoma (MCL): Revealing the Biology Beneath the Mantle and Modern Therapeutic Frontiers

Burkitt Lymphoma: Among the Fastest Growing Yet Most Curable Human Cancers

Diffuse Large B-Cell Lymphoma (DLBCL): Molecular Heterogeneity and Progress in Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: The Current Landscape and Future Perspectives

CancerWorld

Oncologists
Larry Norton

Larry Norton

Oncologists Location New York, USA
Onyinye Balogun

Onyinye Balogun

Oncologists Location New York, USA
David Kerr

David Kerr

Oncologists Location
Thomás Alexandre Santos

Thomás Alexandre Santos

Oncologists Location Rio de Janeiro, Brazil
Sarkis Meterissian

Sarkis Meterissian

Oncologists Location Montreal, Canada
Gilberto Lopes

Gilberto Lopes

Oncologists Location Miami, USA
Darya Kizub

Darya Kizub

Oncologists Location Houston, USA
Jan Fagerberg

Jan Fagerberg

Oncologists Location Paris, France

Oncology Drugs
OTX-2002: Innovative MYC-Targeting mRNA Therapy, Dose, Administration, and Clinical Trials

OTX-2002: Innovative MYC-Targeting mRNA Therapy, Dose, Administration, and Clinical Trials

mRNA-4359: Promising Cancer Vaccine, Dose, Administration, and Clinical Trials

BXCL701: Promising Innate Immune Activation, Dose, Administration, And Clinical Trials

NBTXR3: Promising Radioenhancer, Administration, Dose, And Clinical Trials

KT-333: Promising STAT3 Degradation, Dose, Administration, And Clinical Trials

Veliparib: Mechanism, Dose, Administration, And Clinical Trials

Adavosertib: Mechanism, Dose, Administration, And Clinical Trials

OncoDaily Magazine

New Paper Alert
Alicia D'Souza

Alicia D'Souza: Can New ADC Payloads Overcome Resistance and Expand Treatment Options?

Bibek Aryal

Bibek Aryal: Introducing the Value Cube for Global Oncology

Enrique Grande

Enrique Grande: Rethinking Bladder Preservation in Muscle-Invasive Bladder Cancer

Salman Punekar

Salman Punekar: Daraxonrasib Marks a New Era for RAS-Mutated Lung Cancer

Sacrococcygeal Teratomas

New Paper Alert: Multidisciplinary Management of Altman Type III Sacrococcygeal Teratomas in Benin

Jithma Abeykoon

Jithma Abeykoon: NGS Profiling Is Essential for All Rosai-Dorfman Disease Tumors

OncoDaily Medical Journal

Pediatric Oncology

10.69690/ODMJ-011-0826-7849

Integrated Management of Endo and Exo-pelvic Sacrococcygeal Teratomas (Altman type III): Report of Two Cases
Case Reports & Case Series

Oncology Nursing

10.69690/ODMJ-001-0826-7778

Real-World Patterns of Immune-Related Toxicity in Gastrointestinal Cancer Patients Treated with Immunotherapy: A service evaluation
Original Research

Oncology Nursing

10.69690/ODMJ-002-0826-7795

Late presentation in cancer care: Implications for treatment and survival: A Narrative Review
Reviews

GI Oncology

10.69690/ODMJ-018-0826-7959

From Plate to Polyps: Dietary N-Nitrosamines and Biomarkers of DNA Damage
Abstracts

Head and Neck Cancer

10.69690/ODMJ-018-0826-7933

A Service Review of PD-L1 Biomarker Use in the Head and Neck Cancer Service
Abstracts

Radiation Oncology

10.69690/ODMJ-018-0826-7920

Short-Course Palliative Radiotherapy for Tumour-Related Bleeding in End-of-Life Care: A Focused Literature Review
Abstracts

Pediatric Oncology

10.69690/ODMJ-018-0826-7952

FLASH radiotherapy: A Potential Way to Protect the Developing Brain in Pediatric Oncology
Abstracts

GI Oncology

10.69690/ODMJ-018-0826-7947

Real World Clinical Insights in Combination of Trifluridine-Tipiracil with Bevacizumab for Metastatic Colorectal Cancer
Abstracts